1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA CHERP CTRPv2 pan-cancer AAC 0.19 2e-07
mRNA KDM2B CTRPv2 pan-cancer AAC 0.2 2e-07
mRNA SF1 CTRPv2 pan-cancer AAC 0.19 2e-07
mRNA ZNF491 CTRPv2 pan-cancer AAC 0.17 2e-07
mRNA LTBR CTRPv2 pan-cancer AAC -0.21 2e-07
mRNA ZC3H4 CTRPv2 pan-cancer AAC 0.19 2e-07
mRNA KMT5C CTRPv2 pan-cancer AAC 0.18 2e-07
mRNA CHAF1B CTRPv2 pan-cancer AAC 0.17 2e-07
mRNA SEZ6 CTRPv2 pan-cancer AAC 0.17 2e-07
mRNA SUGP1 CTRPv2 pan-cancer AAC 0.18 2e-07
Download CSV